Your search returned 362 results.

Results
	1.	Consideration of an association between performance status and ramucirumab efficacy. [electronic resource] by Yoon, H H Bendell, J C Wainberg, Z A Producer: 20180118 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Re: Ramucirumab plus Docetaxel versus Placebo plus Docetaxel in Patients with Locally Advanced or Metastatic Urothelial Carcinoma after Platinum-Based Therapy (RANGE): A Randomised, Double-Blind, Phase 3 Trial. [electronic resource] by Chang, Sam S Producer: 20190524 In: The Journal of urology vol. 201 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status. [electronic resource] by Roviello, G Pacifico, C Polom, K Roviello, F Generali, D Producer: 20180118 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Ramucirumab treatment in hepatocellular carcinoma. [electronic resource] by Longo, Federico Carrato, Alfredo Producer: 20211019 In: Chinese clinical oncology vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Response to Letter to the Editor, 'Pharmacokinetics partly explains the relationship between CEA level and survival of colorectal cancer patients treated with ramucirumab,' by Ibrahim et al. [electronic resource] by Yoshino, Takayuki Hsu, Yanzhi Nasroulah, Federico Producer: 20181031 In: European journal of cancer (Oxford, England : 1990) vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein. [electronic resource] by Zhu, Andrew X Finn, Richard S Galle, Peter R Llovet, Josep M Kudo, Masatoshi Producer: 20200602 In: The Lancet. Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab. [electronic resource] by Ibrahim, Sajida Raoul, William Lecomte, Thierry Paintaud, Gilles Ternant, David Producer: 20181031 In: European journal of cancer (Oxford, England : 1990) vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Ramucirumab plus pembrolizumab: can we make the maths work? [electronic resource] by Klempner, Samuel J Wainberg, Zev A Producer: 20200615 In: The Lancet. Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Ramucirumab and the controversial role of α-fetoprotein in hepatocellular carcinoma. [electronic resource] by Abou-Alfa, Ghassan K Producer: 20200602 In: The Lancet. Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. [electronic resource] by Sashegyi, Andreas Zhang, Yawei Lin, Yong Binder, Polina Ferry, David Producer: 20171026 In: Journal of chemotherapy (Florence, Italy) vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	No clear role for angiogenesis inhibitors in first-line therapy for stomach cancer. [electronic resource] by Cats, Annemieke Producer: 20200602 In: The Lancet. Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Ramucirumab Clinical Development: an Emerging Role in Gastrointestinal Tumors. [electronic resource] by Sanchez-Gastaldo, Amparo Gonzalez-Exposito, Reyes Garcia-Carbonero, Rocío Producer: 20171030 In: Targeted oncology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Critical treatment choices for patients with platinum-refractory urothelial carcinoma. [electronic resource] by Lotan, Yair Meng, Xiaosong Producer: 20200618 In: The Lancet. Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	REACH-2: first biomarker-based anti-angiogenic therapy in patients with advanced hepatocellular carcinoma. [electronic resource] by Chon, Hong Jae Kim, Chan Producer: 20200917 In: Chinese clinical oncology vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	[Effectiveness of Ramucirumab Therapy for Advanced Gastric Cancer after Stent Placement for Esophagogastric Junction Carcinoma Obstruction-A Case Report]. [electronic resource] by Takeuchi, Taihei Yuasa, Yasuhiro Okitsu, Hiroshi Maki, Hidenori Tsuneki, Takao Matsuo, Yuta Edagawa, Hiroshi Mori, Osamu Miyamoto, Naoki Eto, Syohei Fujiwara, Satoshi Tomibayashi, Atsushi Ishikura, Hisashi Producer: 20190828 In: Gan to kagaku ryoho. Cancer & chemotherapy vol. 46 Availability: No items available. Save to lists Add to cart (remove)
	16.	[New angiogenesis inhibitor Ramucirumab: longer survival and better symptom control]. [electronic resource] by Lordick, Florian Producer: 20160209 In: Oncology research and treatment vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Ramucirumab Plus Paclitaxel: A Possible New Chemotherapy Regimen for Neuroendocrine Carcinoma of the Stomach. [electronic resource] by Motoo, Yoshiharu Producer: 20180402 In: Internal medicine (Tokyo, Japan) vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2. [electronic resource] by Kudo, Masatoshi Galle, Peter R Llovet, Josep M Finn, Richard S Vogel, Arndt Motomura, Kenta Assenat, Eric Merle, Philippe Brandi, Giovanni Daniele, Bruno Okusaka, Takuji Tomášek, Jiří Borg, Christophe Dadduzio, Vincenzo Morimoto, Manabu Pracht, Marc Jen, Min-Hua Drove Ubreva, Nora Widau, Ryan C Shinozaki, Kenta Yoshikawa, Reigetsu Zhu, Andrew X Producer: 20210621 In: Liver international : official journal of the International Association for the Study of the Liver vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Tracheoesophageal Fistula in a Patient With Advanced NSCLC Who Received Chemoradiotherapy and Ramucirumab. [electronic resource] by Abada, Paolo B Producer: 20191105 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	[Ramucirumab-paclitaxel as second-line therapy for advanced gastric cancer: Poliambulanza experience]. [electronic resource] by Aroldi, Francesca Ogliosi, Chiara Zaniboni, Alberto Producer: 20180426 In: Recenti progressi in medicina vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 362 results.